Piperidin-4-yl-amide derivatives and their use as SST receptor subtype 5 antagonists

Details for Australian Patent Application No. 2006254256 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Christ, Andreas; Binggeli, Alfred; Martin, Rainer Eugen; Guba, Wolfgang; Mohr, Peter; Green, Luke Gideon Granville; Maerki, Hans-Peter

Agent Spruson & Ferguson

Pub. Number AU-B-2006254256

PCT Pub. Number WO2006/128803

Priority 05104774.4 02.06.05 EP

Filing date 23 May 2006

Wipo publication date 7 December 2006

Acceptance publication date 12 April 2012

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/128803 Priority application(s): WO2006/128803

12 April 2012 Application Accepted

  Published as AU-B-2006254256

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254266-Injection appliance and method

2006254255-3-methanesulfonylquinolines as GABAB enhancers